Petros Pharmaceuticals, Inc.
PTPI
$0.0302
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -19.40% | -72.18% | -78.33% | 1.02% | 33.18% |
| Total Receivables | -- | -81.31% | -34.50% | -31.06% | -18.44% |
| Inventory | -- | 7.36% | 22.14% | 30.62% | 34.46% |
| Prepaid Expenses | -95.13% | -86.64% | 71.85% | 113.93% | 174.04% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 433.29% | -99.20% | 89.13% | 76.98% | 37.83% |
| Total Current Assets | -19.20% | -64.23% | -56.11% | 6.30% | 28.76% |
|
|
|||||
| Total Current Assets | -19.20% | -64.23% | -56.11% | 6.30% | 28.76% |
| Net Property, Plant & Equipment | -- | -46.43% | -50.85% | -45.94% | -40.30% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -64.28% | -30.15% | -28.83% | -27.70% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -20.24% | -- | -32.09% | -25.37% | -19.39% |
| Total Assets | -41.92% | -68.53% | -46.82% | -12.38% | -0.84% |
|
|
|||||
| Total Accounts Payable | -64.60% | 35.94% | 18.15% | -55.65% | 15.01% |
| Total Accrued Expenses | -88.63% | 9.04% | 22.11% | -21.31% | 25.98% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 470.47% | 80.57% | 51.87% | 23.95% |
| Total Finance Division Other Current Liabilities | 353.43% | 7.66% | 67.19% | 103.75% | 142.59% |
| Total Other Current Liabilities | 353.43% | 7.66% | 67.19% | 103.75% | 142.59% |
| Total Current Liabilities | 141.83% | 67.38% | 55.43% | 25.25% | 62.95% |
|
|
|||||
| Total Current Liabilities | 141.83% | 67.38% | 55.43% | 25.25% | 62.95% |
| Long-Term Debt | -- | -- | -32.09% | -25.37% | -19.39% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -45.39% | -39.37% | -41.19% | -44.99% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -96.83% | -- | -- | -- | -- |
| Total Liabilities | 38.59% | -15.07% | -44.83% | 1.27% | 29.73% |
|
|
|||||
| Common Stock & APIC | -4.47% | -4.70% | 0.86% | 2.03% | 3.05% |
| Retained Earnings | -14.27% | -14.48% | -4.76% | -7.45% | -9.71% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -197.93% | -161.86% | -55.06% | -37.65% | -36.65% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -98.88% | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -98.88% | -- | -- |
|
|
|||||
| Total Common Equity | -197.93% | -161.86% | -55.06% | -37.65% | -36.65% |
| Total Preferred Equity | -- | -- | -98.88% | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -189.63% | -159.84% | -55.83% | -29.03% | -30.78% |
|
|
|||||